InpharmD, which uses artificial intelligence plus human curation to answer drug information questions, seeks to overcome some of the more challenging limitations of current AI programs, not the least of which is a troubling tendency to make up fake clinical references or omit key findings that can compromise patient care.
The need for better AI systems is acute. In 2023, researchers at New York’s Long Island University found that the AI system ChatGPT incorrectly answered